Open Your FREE Demat Account Now!

Mahamaya Lifesciences Ltd. Share Price

NSE
BSE

BSE : 544611

Sector : Chemicals

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Low

₹

High

₹

Price Summary

Previous Close ₹171.00
Day's Range ₹171.00 - ₹171.00
Open ₹171.00
52 Week Range ₹111.00 - ₹205.05
Volume 1,200
Market Cap ₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs) 2.05
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.00
Price/Earning (TTM) 24.22
TTM EPS (₹) 7.06
P/E Ratio 21.32
Book Value(₹) 3.28
PAT Margin (%) 5.02
Face Value (₹) 10.00
ROCE(%) 20.27

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales N/A 2657.51
Expenses N/A N/A
PBT N/A 172.52
Operating profit N/A 0.0
Net profit N/A 128.12

Shareholding Pattern

Promoters (% Holding)

56.39%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

38.94%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

2.66%

About Mahamaya Lifesciences Ltd.

Founded 2016
Managing Director Krishnamurthy Ganesan

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Asian Paints Ltd. 2,20,490.80 2,298.70 2,115.00 - 2,115.00
Solar Industries India Ltd. 1,75,804.08 19,428.00 11,646.00 - 11,646.00
Pidilite Industries Ltd. 1,44,774.87 1,421.40 1,259.00 - 1,259.00
SRF Ltd. 69,806.56 2,354.95 2,178.30 - 2,178.30
Berger Paints India Ltd. 54,370.71 467.55 391.10 - 391.10
Coromandel International Ltd. 50,712.12 1,718.70 1,651.10 - 1,651.10
Gujarat Fluorochemicals Ltd. 47,077.32 4,298.00 2,916.60 - 2,916.60
UPL Ltd. 45,753.98 542.00 476.45 - 476.45
The Fertilisers And Chemicals Travancore Ltd. 44,557.38 687.90 652.10 - 652.10
Navin Fluorine International Ltd. 42,574.44 8,294.00 4,890.70 - 4,890.70
no-content No Records Found

Latest News

Sep
30
2026
EQUITY Posted on Sep 30th 2026

Mahamaya Lifesciences informs about change in management

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Part A of Schedule III of the said Regulations, Mahamaya Lifesciences has informed that the members of the Company, based on the recommendations of Board of Directors & Nomination and Remuneration Committee approved the following resolutions at their meeting held on Tuesday, September 29, 2026, at 11:00 AM: Appointment of Dr. Bhagirath Choudhary as Independent Director, Re-appointment of Dr. Charudatta Digambar Mayee as Independent Director, Re-appointment of Gopal Krishna Raju as Independent Director, Re-designation of Krishnamurthy Ganesan as Chairman, and Re-designation of Prashant Krishnamurthy as Managing Director.
The above information is a part of company’s filings submitted to BSE.
Read More
Oct
29
2026
EQUITY Posted on Oct 29th 2026

Prasol Chemicals informs about conference call

Pursuant to Regulation 30 of the Listing Regulations, Prasol Chemicals has informed that the Quarterly Earnings Conference Call for Investors and Analysts is scheduled to be held on Tuesday, November 3, 2026, at 11 am IST to discuss the Q2 FY27 results. The company has attached invitation for the same. No Unpublished Price Sensitive Information will be shared during the call and Date and participants of the aforesaid meet is subject to change due to exigencies on the part of Organisers/ Investors/ Analysts/ Company/ Participants.

The above information is a part of company’s filings submitted to BSE.

Read More
Oct
29
2026
EQUITY Posted on Oct 29th 2026

OCCL informs about board meeting

Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, OCCL has informed that a meeting of Board of Directors of the Company will be held on Friday, November 06, 2026, to consider and approve the Un-audited Financial Results of the Company for the quarter ended September 30, 2026. Further, the Board may consider and approve an Interim Dividend on equity shares, if any, for the Financial Year 2026-2027 at the said meeting. Further, pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company’s Code of Conduct for Prohibition of Insider Trading, the Trading Window has been closed for the Designated Persons and their immediate relatives with effect from October 01, 2026, and will be re-open after expiry of 48 hours of submitting the above referred Financial Results to the Stock Exchanges. 

The above information is a part of company’s filings submitted to BSE.

Read More
Oct
29
2026
EQUITY Posted on Oct 29th 2026

TCM informs about board meeting

TCM has informed that a Meeting of the Board of Directors would be held on Friday, 06th November 2026 at 02:00 PM at the Registered Office of the Company consider and approve: 1. The Consolidated and Standalone Unaudited Financial Results of the Company for the quarter ended 30th September 2026 2. Any other matter with the permission of the Chair. Further, in continuation of its intimation dated 29th September 2026 regarding closure of Trading Window, the company has re-iterated that the trading window shall re-open after 48 hours from the declaration of the financial results.

The above information is a part of company’s filings submitted to BSE.

Read More
Oct
29
2026
EQUITY Posted on Oct 29th 2026

TANFAC Industries informs about conference call

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, TANFAC Industries has informed that the Conference call is scheduled to be held on Tuesday, 03rd November, 2026 at 10:00 am (IST). The aforesaid information will also be disclosed on the website of the Company: https://tanfac.com/investors/investor-information/calls-conferences-and-transcripts

The above information is a part of company’s filings submitted to BSE.

Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Mahamaya Lifesciences Ltd. ?

The current share price of Mahamaya Lifesciences Ltd. is ₹171.00 as of 2026-10-28.

The market capitalisation of Mahamaya Lifesciences Ltd. is ₹400.23 as of 2026-10-28.

The 1-year return of Mahamaya Lifesciences Ltd. is % as of .

The P/E ratio of Mahamaya Lifesciences Ltd. is 21.32 as of 2026-10-30.

The 52-week high and low of Mahamaya Lifesciences Ltd. are ₹205.05 and ₹111.00, respectively, as of 2026-10-28.

The dividend yield of Mahamaya Lifesciences Ltd. is 0.0% as of2026-10-28.

You can buy Mahamaya Lifesciences Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Mahamaya Lifesciences Ltd. is Krishnamurthy Ganesan.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore